Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Taxane Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101448839B details a safer, scalable route for 13-(N-Boc-β-isobutylserinyl)-14-β-hydroxybaccatin III, eliminating phosgene hazards and chromatography.
Patent CN110105368B reveals novel deoxy taxane synthesis improving solubility and anticancer activity, offering cost-effective API intermediate manufacturing strategies.
Patent CN1100144A details enzymatic resolution for high-purity taxane intermediates, offering cost-effective and scalable pharmaceutical manufacturing solutions.
Patent CN1774430A details a novel sulfolane-based cyclopropanation for taxane intermediates, offering improved purity and scalable manufacturing for API production.